Comparison of the clinical effects between Nova Sure endometrial ablation and transcervical resection of endometrium in treatment of abnormal uterine bleeding
Abstract：ObjectiveTo compare the effectivness and safety between Nova Sure endometrial ablation and transcervical resection of endometrium (TRCE) in treatment of abnormal uterine bleeding (AUB).MethodsSixty AUB patients whose previous medications were ineffective were selected from January 2015 to January 2017, and were randomly divided into study group (n=30) and control group (n=30).The study group was treated with Nova Sure, and the control group was treated with TRCE.All the patients were followed up respectively at 1, 3, 6, and 12months after operation to determine their response to the treatment and the incidence of complications.Results The menstrual blood volume was significantly reduced in all the patients after operation, but there were no significant differences in effective rate and amenorrhea rate between the two groups (P＞0.05).The operation time of the study group was significantly shorter than that of the control group (P＜0.05).The intraoperative blood loss of the study group was significantly less than that of the control group (P＜0.05).The intraoperative and postoperative complications of the study group were less than those of the control group, but there were only significant differences in electrolyte disturbance and abdominal pain 1 and 3 months after operation between the two group (P＜0.05).ConclusionBoth Nova Sure and TRCE are effective in treatment of AUB, but Nova Sure treatment may be safer.
Keywords：Nova SureTranscervical resection of endometrium (TRCE)Abnormal uterine bleeding (AUB)EffectivenessSafety
Publication Date：2019-01-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：4( 43-46 )